Natural Capsules Limited

NATCAPSUQ6

INE936B01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-07-12 am EDT			5-day change	1st Jan Change
320.9 ^INR	-0.40%		+0.53%	-10.80%

May. 21	Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
May. 21	Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Natural Capsules Limited Appoints Anjan K Roy as Additional Non-Executive Independent Director with Immediate Effect for Period of 5 Years

July 30, 2018 at 10:58 am EDT

Natural Capsules Limited has appointed Mr. Anjan K Roy as Additional Non-Executive Independent Director with immediate effect for a period of 5 years. Currently he is the promoter and co-founder of RL Fine Chern Private Limited. Mr. Anjan K Roy is not related to any Director of the Company.

Latest news about Natural Capsules Limited

Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 21	CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 21	CI
Natural Capsules Begins Production in First High-Speed HPMC Line	Mar. 18	MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
Natural Capsules Raises INR750 Million from Somerset Indus Capital Partners	23-06-22	MT
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-26	CI
Natural Capsules Limited Recommends Dividend	23-05-26	CI
Natural Biogenex Private Limited announced that it expects to receive INR 750.000038 million in funding from Natural Capsules Limited, Somerset Indus Capital Partners	23-04-21	CI
Natural Capsules Unit Gets INR 6.3 Million Investment	23-03-07	MT
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-10	CI
Natural Capsules Approves Resignation of Mr. Anjan Kumar as Independent Director	22-08-10	CI
Natural Capsules Sees Surge in Fiscal Q4 Consolidated Net Profit	22-05-11	MT
Natural Capsules' Consolidated Net Profit Soars in Fiscal Q4	22-05-10	MT
Natural Capsules Names New CFO	22-05-10	MT
Natural Capsules Limited Announces Chief Financial Officer Changes	22-05-10	CI
Natural Capsules Limited Recommends Dividend	22-05-10	CI
Natural Capsules Limited Recommends Dividend	22-05-09	CI
Natural Capsules Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-09	CI
Natural Capsules Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-09	CI
Natural Capsules Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-08	CI
Natural Capsules Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-30	CI
Natural Capsules Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	21-08-07	CI

Chart Natural Capsules Limited

Duration

Period

More charts

Company Profile

Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in the manufacturing of vegetarian capsules. The Company's product portfolio includes capsules and steroidal active pharmaceutical ingredients (APIs). Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. The Company exports its products to over 30 countries. It has two manufacturing facilities that are located in Bengaluru and Puducherry. It has a production capacity of around five million capsules per machine per day.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NATURAL CAPSULES LIMITED	-10.80%	35.83M
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B